These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12190177)

  • 1. Subacute liver failure in obese women.
    Caldwell SH; Hespenheide EE
    Am J Gastroenterol; 2002 Aug; 97(8):2058-62. PubMed ID: 12190177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
    McCullough AJ
    Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease.
    Charlton M; Kasparova P; Weston S; Lindor K; Maor-Kendler Y; Wiesner RH; Rosen CB; Batts KP
    Liver Transpl; 2001 Jul; 7(7):608-14. PubMed ID: 11460228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis.
    Contos MJ; Cales W; Sterling RK; Luketic VA; Shiffman ML; Mills AS; Fisher RA; Ham J; Sanyal AJ
    Liver Transpl; 2001 Apr; 7(4):363-73. PubMed ID: 11303298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.
    Harrison SA; Torgerson S; Hayashi PH
    Am J Gastroenterol; 2003 Sep; 98(9):2042-7. PubMed ID: 14499785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of nonalcoholic steatohepatitis.
    Liou I; Kowdley KV
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S11-6. PubMed ID: 16540761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.
    Caldwell SH; Oelsner DH; Iezzoni JC; Hespenheide EE; Battle EH; Driscoll CJ
    Hepatology; 1999 Mar; 29(3):664-9. PubMed ID: 10051466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liver disease in obese patients].
    Giostra E; Huber O; Morel P; Hadengue A
    Rev Med Suisse; 2007 Sep; 3(123):1939-41. PubMed ID: 17918488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.
    Beymer C; Kowdley KV; Larson A; Edmonson P; Dellinger EP; Flum DR
    Arch Surg; 2003 Nov; 138(11):1240-4. PubMed ID: 14609874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease.
    Willner IR; Waters B; Patil SR; Reuben A; Morelli J; Riely CA
    Am J Gastroenterol; 2001 Oct; 96(10):2957-61. PubMed ID: 11693332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.
    Ong J; Younossi ZM; Reddy V; Price LL; Gramlich T; Mayes J; Boparai N
    Liver Transpl; 2001 Sep; 7(9):797-801. PubMed ID: 11552214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus, obesity, and hepatic steatosis.
    Youssef W; McCullough AJ
    Semin Gastrointest Dis; 2002 Jan; 13(1):17-30. PubMed ID: 11944630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of nonalcoholic fatty liver: a follow-up study.
    Teli MR; James OF; Burt AD; Bennett MK; Day CP
    Hepatology; 1995 Dec; 22(6):1714-9. PubMed ID: 7489979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass.
    Boza C; Riquelme A; Ibañez L; Duarte I; Norero E; Viviani P; Soza A; Fernandez JI; Raddatz A; Guzman S; Arrese M
    Obes Surg; 2005 Sep; 15(8):1148-53. PubMed ID: 16197788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C.
    Sanyal AJ; Banas C; Sargeant C; Luketic VA; Sterling RK; Stravitz RT; Shiffman ML; Heuman D; Coterrell A; Fisher RA; Contos MJ; Mills AS
    Hepatology; 2006 Apr; 43(4):682-9. PubMed ID: 16502396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Liver cirrhosis in diabetes mellitus; a complication not always recognized].
    Thewissen CM; Tiebosch AT; Kloppenburg WD; Haagsmna EB; Hoogenberg K
    Ned Tijdschr Geneeskd; 2008 Nov; 152(44):2369-74. PubMed ID: 19055132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis.
    Serfaty L; Lemoine M
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):634-7. PubMed ID: 19195623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.